John B. Kisiel

4.7k total citations · 1 hit paper
178 papers, 2.7k citations indexed

About

John B. Kisiel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, John B. Kisiel has authored 178 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 56 papers in Surgery. Recurrent topics in John B. Kisiel's work include Colorectal Cancer Screening and Detection (76 papers), Gastric Cancer Management and Outcomes (54 papers) and Genetic factors in colorectal cancer (45 papers). John B. Kisiel is often cited by papers focused on Colorectal Cancer Screening and Detection (76 papers), Gastric Cancer Management and Outcomes (54 papers) and Genetic factors in colorectal cancer (45 papers). John B. Kisiel collaborates with scholars based in United States, South Korea and Thailand. John B. Kisiel's co-authors include David A. Ahlquist, Douglas W. Mahoney, Tracy C. Yab, Thomas C. Smyrk, William R. Taylor, Edward V. Loftus, Prasad G. Iyer, Lewis R. Roberts, Paul J. Limburg and Mary E. Devens and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

John B. Kisiel

167 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening

2024 80 citations Thomas F. Imperiale, John B. Kisiel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John B. Kisiel United States	28	1.1k	754	728	660	628	178	2.7k
Claudia Mescoli Italy	28	810 0.7×	463 0.6×	367 0.5×	992 1.5×	381 0.6×	110	2.6k
Leticia Moreira Spain	21	860 0.7×	758 1.0×	404 0.6×	494 0.7×	709 1.1×	85	2.3k
Li‐Xin Qiu China	28	953 0.8×	1.4k 1.9×	597 0.8×	309 0.5×	767 1.2×	113	2.8k
Hye Seung Han South Korea	27	683 0.6×	596 0.8×	734 1.0×	766 1.2×	258 0.4×	107	2.3k
Carmela Di Gregorio Italy	33	1.8k 1.6×	622 0.8×	679 0.9×	727 1.1×	652 1.0×	88	3.2k
Laura A. Cisar United States	21	2.1k 1.8×	707 0.9×	916 1.3×	502 0.8×	590 0.9×	38	3.1k
Francisco Rodríguez‐Moranta Spain	25	755 0.7×	408 0.5×	341 0.5×	560 0.8×	265 0.4×	88	1.8k
Mee Soo Chang South Korea	26	744 0.6×	515 0.7×	306 0.4×	460 0.7×	299 0.5×	106	2.2k
Wei‐Hua Jia China	30	979 0.9×	1.4k 1.8×	339 0.5×	352 0.5×	1.1k 1.7×	104	2.8k
Timothy L. Frankel United States	28	1.5k 1.3×	663 0.9×	557 0.8×	543 0.8×	407 0.6×	81	2.6k

Countries citing papers authored by John B. Kisiel

Since Specialization

Citations

This map shows the geographic impact of John B. Kisiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Kisiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Kisiel more than expected).

Fields of papers citing papers by John B. Kisiel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Kisiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Kisiel. The network helps show where John B. Kisiel may publish in the future.

Co-authorship network of co-authors of John B. Kisiel

This figure shows the co-authorship network connecting the top 25 collaborators of John B. Kisiel. A scholar is included among the top collaborators of John B. Kisiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John B. Kisiel. John B. Kisiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Estes, Chris, William K. Johnson, Michaël Doré, et al.. (2025). Multi-Target Stool DNA and the Fecal Immunochemical Test: A Systematic Review and Meta-Analysis on Test Performances. American Journal of Preventive Medicine. 69(2). 107654–107654. 1 indexed citations

Kisiel, John B., A. Mark Fendrick, A. Burak Ozbay, et al.. (2024). Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening. Journal of Medical Economics. 27(1). 746–753. 5 indexed citations

Witzig, Thomas E., William R. Taylor, Douglas W. Mahoney, et al.. (2024). Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot. American Journal of Hematology. 100(2). 218–228. 3 indexed citations

Bhattacharya, Abhik, Douglas W. Mahoney, David K. Edwards, et al.. (2024). Next-generation Multi-target Stool DNA Panel Accurately Detects Colorectal Cancer and Advanced Precancerous Lesions. Cancer Prevention Research. 17(3). 119–126. 9 indexed citations

Taylor, William R., Douglas W. Mahoney, Calise K. Berger, et al.. (2023). Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies. Cancers. 15(24). 5778–5778. 4 indexed citations

Pham, Jonathan, John B. Kisiel, & Seth Sweetser. (2023). Cronkhite-Canada syndrome: treatment responses and improved overall survival. International Journal of Colorectal Disease. 38(1). 39–39. 4 indexed citations

Kisiel, John B., Lianne Barnieh, Nathaniel Smith, et al.. (2023). The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population. Journal of Medical Economics. 26(1). 1219–1226. 4 indexed citations

Limburg, Paul J., Steven H. Itzkowitz, David A. Lieberman, et al.. (2023). Tu1116 ESTIMATED IMPACT OF ADENOMA AND COLORECTAL CANCER EARLY DETECTION ON HEALTH OUTCOMES AND SCREENING EFFECTIVENESS. Gastroenterology. 164(6). S–984. 1 indexed citations

Bakkum‐Gamez, Jamie N., Seth W. Slettedahl, Patrick H. Foote, et al.. (2023). Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers. Cancer Prevention Research. 16(11). 611–620. 3 indexed citations

10.

Bartemes, Kathleen R., David M. Routman, J. Daniel, et al.. (2023). Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease. Oral Oncology. 146. 106568–106568.

11.

Taylor, William R., et al.. (2022). Assessment of extracellular vesicle isolation methods from human stool supernatant. Journal of Extracellular Vesicles. 11(4). e12208–e12208. 44 indexed citations

12.

Majumder, Shounak, William R. Taylor, Patrick H. Foote, et al.. (2021). High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9. Clinical Cancer Research. 27(9). 2523–2532. 34 indexed citations

13.

Sinicrope, Frank A., Thomas R. Viggiano, Navtej Buttar, et al.. (2021). Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia. Cancer Prevention Research. 14(5). 573–580. 26 indexed citations

14.

Ramos, Guilherme Piovezani, Badr Al‐Bawardy, Manuel B. Braga Neto, et al.. (2021). Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience. Crohn s & Colitis 360. 3(3). otab019–otab019. 2 indexed citations

15.

Imperiale, Thomas F., et al.. (2021). Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45–49 Year-Olds: A Cross-Sectional Study. Cancer Prevention Research. 14(4). 489–496. 39 indexed citations

16.

Xie, Hao, Douglas W. Mahoney, Patrick H. Foote, et al.. (2020). Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence. Clinical Cancer Research. 27(1). 141–149. 20 indexed citations

17.

Qin, Yi, Chung Wah Wu, William R. Taylor, et al.. (2019). Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma. Clinical Cancer Research. 25(24). 7396–7404. 40 indexed citations

18.

Suh, Yun‐Suhk, Boram Choi, Hyuk‐Joon Lee, et al.. (2018). Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma. Clinical Cancer Research. 24(22). 5724–5734. 47 indexed citations

19.

Cotter, Thomas G., Kelli N. Burger, Mary E. Devens, et al.. (2016). Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 26(4). 614–621. 24 indexed citations

20.

Kisiel, John B., Massimo Raimondo, William R. Taylor, et al.. (2015). New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice. Clinical Cancer Research. 21(19). 4473–4481. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact